Microbiologist Explains COVID Jab Effects

• The FDA can only grant emergency use authorization for a pandemic drug or vaccine if there’s no safe and effective preexisting treatment or alternative. Since there are several such alternatives, the FDA is legally required to revoke the emergency authorization for these shots
• While the COVID injections have been characterized as being somewhere around 95% effective against SARS-CoV-2 infection, this is the relative risk reduction, which tells you very little about its usefulness. The absolute risk reduction is only around 1% for all currently available COVID shots
• Antibody-dependent enhancement (ADE) refers to a condition where the vaccination augments your risk of serious infection. We are now starting to see evidence that ADE is occurring in the vaccinated population
• One of the most common side effects of the COVID shots is abnormal blood clotting, which can result in strokes and heart attacks
• Even microclots that don’t completely block the blood vessel can have serious ramifications. You can check for presence of microclots by performing a D-dimer blood test. If your D-dimer is elevated, you have clotting somewhere in your body

How Effective Are the COVID Shots?

While the COVID injections have been characterized as being somewhere around 95% effective against SARS-CoV-2 infection, this claim is the product of statistical obfuscation. In short, they’ve conflated relative risk reduction and absolute risk reduction. The absolute risk reduction is actually right around 1% for all currently available COVID shots.¹

In “Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials”² Ron Brown, Ph.D. calculates the absolute risk reduction for Pfizer’s and Moderna’s injections, based on their own clinical trial data, so that they can be compared to the relative risk reduction reported by these companies. Here’s a summary of his findings:

• Pfizer/BioNTech vaccine BNT162b2 — Relative risk reduction: 95.1%. Absolute risk reduction: 0.7%
• Moderna vaccine mRNA-1273 — Relative risk reduction: 94.1%. Absolute risk reduction 1.1%

In a July 1, 2021, commentary in The Lancet Microbe,³ Piero Olliaro, Els Torreele and Michel Vaillant also argue for the use of absolute risk reduction when discussing vaccine efficacy with the public. They too went through the calculations, coming up with the following:

• Pfizer/BioNTech — Relative risk reduction: 95%. Absolute risk reduction: 0.84%
• Moderna — Relative risk reduction: 94%. Absolute risk reduction: 1.2%
• Gamaleya (Sputnic V) — Relative risk reduction: 91%. Absolute risk reduction: 0.93%
• Johnson & Johnson — Relative risk reduction: 67%. Absolute risk reduction: 1.2%
• AstraZeneca/Oxford — Relative risk reduction: 67%. Absolute risk reduction: 1.3%

Read full story [icon name=”arrow-right” prefix=”fas”] Microbiologist Explains COVID Jab Effects